Population pharmacokinetic and pharmacodynamic analysis of plasma Aβ40 and Aβ42 following single oral doses of the BACE1 inhibitor AZD3839 to healthy volunteers.
about
BACE1 across species: a comparison of the in vivo consequences of BACE1 deletion in mice and ratsFuture Therapeutics in Alzheimer's Disease: Development Status of BACE Inhibitors.Potent and Selective BACE-1 Peptide Inhibitors Lower Brain Aβ Levels Mediated by Brain Shuttle Transport.A microfluidics-based mobility shift assay to identify new inhibitors of β-secretase for Alzheimer's disease.AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease.
P2860
Population pharmacokinetic and pharmacodynamic analysis of plasma Aβ40 and Aβ42 following single oral doses of the BACE1 inhibitor AZD3839 to healthy volunteers.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Population pharmacokinetic and ...... AZD3839 to healthy volunteers.
@en
Population pharmacokinetic and ...... AZD3839 to healthy volunteers.
@nl
type
label
Population pharmacokinetic and ...... AZD3839 to healthy volunteers.
@en
Population pharmacokinetic and ...... AZD3839 to healthy volunteers.
@nl
prefLabel
Population pharmacokinetic and ...... AZD3839 to healthy volunteers.
@en
Population pharmacokinetic and ...... AZD3839 to healthy volunteers.
@nl
P2093
P2860
P356
P1476
Population pharmacokinetic and ...... AZD3839 to healthy volunteers
@en
P2093
Björn Paulsson
Chi-Ming Lee
Erik Sparve
Gunilla Huledal
Johanna Fälting
Jonathan Paraskos
Justine Maltby
Kristina Claeson-Bohnstedt
Maria Lüttgen
Pär Karlsson
P2860
P304
P356
10.1002/CPDD.130
P577
2014-05-26T00:00:00Z